Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates

December 15, 2023

https://www.globenewswire.com/news-release/2023/08/01/2715716/32445/en/Minerva-Neurosciences-Reports-2023-Second-Quarter-Financial-Results-and-Business-Updates.html

BURLINGTON, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (Nasdaq:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today reported business updates and financial results for the second quarter ended June 30, 2023.   

Read more at globenewswire.com

Related news for (NERV)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.